Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine

MeSH terms

• Antimetabolites, Antineoplastic / therapeutic use*
• Azacitidine / therapeutic use*
• Humans
• Myelodysplastic Syndromes / chemically induced
• Myelodysplastic Syndromes / drug therapy*
• Myelodysplastic Syndromes / mortality*
• Neoplasms, Second Primary / chemically induced
• Neoplasms, Second Primary / drug therapy*
• Neoplasms, Second Primary / mortality*
• Treatment Outcome